Published Date: 27 Apr 2023
The field is reaching a point where sleep health will become a top priority for public health as a result of the great strides made in the field over the past year, as well as the effects of the COVID-19 pandemic and lingering care challenges.
Read Full NewsLack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.
A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.
Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.
Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.
1.
Two-part prodrug system activates immune attack only in tumor's unique environment
2.
After all, Pulled Myeloma Drug May Help Treat the Illness.
3.
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL
4.
A Chemo-Free Option for Some Advanced Endometrial Cancers?
5.
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says
1.
A Comprehensive Guide To Understanding Plasma Osmolality
2.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
3.
Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options
4.
Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders
5.
Exploring the Unknown: Unveiling the Mysteries of GIST Tumors
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation